Development of Tracer-Based Metabolomics and its Implications for the Pharmaceutical Industry

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.21, Iss.3, 2007-01, pp. : 217-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolomics and Its Practical Value in Pharmaceutical Industry

Current Drug Metabolism, Vol. 12, Iss. 4, 2011-05 ,pp. : 345-358

Bentham Science Publishers

Access to resources Recommend Favorite

Translational Science in Medicine: Implications for the Pharmaceutical Industry

By Wehling Martin

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 5, 2006-01 ,pp. : 303-310

Adis International

Access to resources Recommend Favorite

Cross-Border Trade Policy Implications for the Pharmaceutical Industry

By Freeman Robert A.

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 3, 2005-07 ,pp. : 71-78

Haworth Press

Access to resources Recommend Favorite

Challenges in Pediatric Drug Development: A Pharmaceutical Industry Perspective

By Rose Klaus

Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. : 57-59

Adis International

Access to resources Recommend Favorite

Recent advances in biocatalyst development in the pharmaceutical industry

By Zhang Mingzi M Su Xiaoyun Ang Ee Lui Zhao Huimin

Pharmaceutical Bioprocessing, Vol. 1, Iss. 2, 2013-06 ,pp. : 179-196

Future Science

Access to resources Recommend Favorite